Table 3.
Clinical Characteristics of Patients REFERRED for GOC RRT Consultation (N=89).
| Characteristic | Total Patients Referred for GOC RRT Consultation (N=89) | Patients’ GOC RRT Consultation Status |
|||
|---|---|---|---|---|---|
| Consultation Completed (N=76) | Consultation Not Completed (N=13) | P value | |||
| Tumor diagnosis N (%) | Solid tumor and non-cancer diagnoses | 42 (47.2%) | 38 (50.0%) | 4 (30.8%) | 0.199 |
| Acute leukemia, MDS, lymphoma, myelofibrosis, myeloma, amyloidosis | 47 (52.8%) | 38 (50.0%) | 9 (69.2%) | ||
| Disease status N (%) | Localized, locally advanced and non-cancer diagnoses | 12 (13.5%) | 11 (14.5%) | 1 (7.7%) | 0.132 |
| Metastatic cancer or leukemia in ≥1 relapse | 73 (82.0%) | 63 (82.9%) | 10 (76.9%) | ||
| Without evidence of cancer ≥1 year | 4 (4.5%) | 2 (2.6%) | 2 (15.4%) | ||
| COVID status at referral N (%) | Confirmed diagnosis | 6 (6.7%) | 5 (6.6%) | 1 (7.7%) | 0.573 |
| Not detected | 75 (84.3%) | 65 (85.5%) | 10 (76.9%) | ||